|
EP3703676A1
|
|
Composition and method for modifying polypeptides
|
|
US2015202314A1
|
|
Site-specific labeling and targeted delivery of proteins for the treatment of cancer
|
|
EP2575897A2
|
|
Crosslinking of proteins and other entities via conjugates of alpha-haloacetophenones, benzyl halides, quinones, and their derivatives
|
|
EP2536287A1
|
|
Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides
|
|
CA2739445A1
|
|
Site specific n-terminal modifications of proteins and conjugate formation
|
|
US2004176575A1
|
|
Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites
|
